Quick Takeaways
- FMR LLC filed SCHEDULE 13G for AGOMAB THERAPEUTICS SA COMMON STOCK.
- Disclosed ownership: 10%.
- Date of event: 27 Feb 2026.
FMR LLC - 27 Feb 2026 SCHEDULE 13G Report for AGOMAB THERAPEUTICS SA COMMON STOCK
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Security
- AGOMAB THERAPEUTICS SA COMMON STOCK
- Shares outstanding
- 48,736,800 shares
- Disclosed Ownership
- 4,873,680 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 06 Mar 2026, 10:05:20 UTC
- Date of event
- 27 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 10% ownership in AGOMAB THERAPEUTICS SA COMMON STOCK on 27 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 06 Mar 2026, 10:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 10% | 4,873,680 | 4,873,680 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 10% | 4,873,680 | 0 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** |